In prognostic analyses, HNSCC patients with low TIM-3+ TILs infiltration had significantly improved survival for all assessed endpoints, as compared to patients with high TIM-3+ TILs. The gene discussed is HAVCR2; the disease is head and neck squamous cell carcinoma.